Medicofarma Biotech SA (WSE:MDB)

Poland · Delayed Price · Currency is PLN

0.3680

-0.0060 (-1.60%)

Last updated: Nov 3, 2026, 3:50 PM CET

Medicofarma Biotech Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	25	27	26	74	79	116
Market Cap Growth	-33.09%	2.83%	-64.24%	-6.06%	-32.05%	483.23%
Enterprise Value	29	30	28	74	78	115
Last Close Price	0.37	0.40	0.39	1.08	1.16	1.70

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	326.37	226.22	21.53	98.24	18.46	34.63
PB Ratio	5.64	4.77	3.84	8.04	6.22	8.14
P/TBV Ratio	5.66	4.81	3.89	8.17	7.09	9.46
P/OCF Ratio	-	-	-	10167.70	81.76	63.64

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	253.67	23.08	98.22	18.26	34.60
EV/EBITDA Ratio	-	-	-	-	451.82	173.24

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.90	0.65	0.37	0.15	-	-
Net Debt / Equity Ratio	0.90	0.65	0.37	0.15	-0.04	0.00
Net Debt / EBITDA Ratio	-79.61	-17.80	-4.81	-2.53	-2.95	-0.12
Net Debt / FCF Ratio	-5.60	-3.77	-2.48	-1.26	2.05	0.16
Asset Turnover	0.01	0.01	0.08	0.05	0.26	0.39
Inventory Turnover	-	-	768.33	13.21	10.67	6.77
Quick Ratio	0.87	1.25	0.85	0.63	0.65	0.73
Current Ratio	0.87	1.25	0.85	0.63	0.69	1.00
Return on Equity (ROE)	-40.48%	-35.52%	-28.67%	-31.57%	-11.85%	-3.08%
Return on Assets (ROA)	-7.00%	-7.35%	-8.73%	-10.50%	-5.95%	-2.07%
Return on Invested Capital (ROIC)	-17.56%	-18.10%	-20.78%	-23.22%	-12.02%	-4.10%
Return on Capital Employed (ROCE)	-17.70%	-16.80%	-20.30%	-24.00%	-12.00%	-1.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-8.09%	-8.22%	-8.72%	-4.66%	-2.02%	-0.19%
FCF Yield	-2.85%	-3.63%	-3.86%	-1.49%	-0.32%	-0.42%
Buyback Yield / Dilution	-	-	-	-	-	-901.99%